Paclitaxel aids in breast cancer survival, research says

05/27/2008 | Washington Post (tiered subscription model), The

Female patients with early non-metastatic breast cancer who received the drug paclitaxel and underwent standard chemotherapy showed improved disease-free survival in a late-stage trial, Spanish scientists reported. Though the study also found a trend toward enhanced overall survival, it failed to achieve statistical significance. Such a benefit "may become evident with a more protracted follow-up," a study author said.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ